- Home
- VEEE vs APLM Comparison
VEEE vs APLM Comparison
Compare VEEE & APLM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VEEE
- APLM
- Stock Information
- Founded
- VEEE 1994
- APLM 2016
- Country
- VEEE United States
- APLM United States
- Employees
- VEEE N/A
- APLM N/A
- Industry
- VEEE Marine Transportation
- APLM Blank Checks
- Sector
- VEEE Industrials
- APLM Finance
- Exchange
- VEEE Nasdaq
- APLM Nasdaq
- Market Cap
- VEEE 5.8M
- APLM 6.1M
- IPO Year
- VEEE 2021
- APLM N/A
- Fundamental
- Price
- VEEE $1.95
- APLM $3.93
- Analyst Decision
- VEEE
- APLM
- Analyst Count
- VEEE 0
- APLM 0
- Target Price
- VEEE N/A
- APLM N/A
- AVG Volume (30 Days)
- VEEE 106.3K
- APLM 22.4K
- Earning Date
- VEEE 08-07-2025
- APLM 09-12-2025
- Dividend Yield
- VEEE N/A
- APLM N/A
- EPS Growth
- VEEE N/A
- APLM N/A
- EPS
- VEEE N/A
- APLM N/A
- Revenue
- VEEE $13,153,262.00
- APLM $198,000.00
- Revenue This Year
- VEEE N/A
- APLM $415.15
- Revenue Next Year
- VEEE N/A
- APLM N/A
- P/E Ratio
- VEEE N/A
- APLM N/A
- Revenue Growth
- VEEE N/A
- APLM N/A
- 52 Week Low
- VEEE $1.88
- APLM $3.66
- 52 Week High
- VEEE $9.30
- APLM $35.98
- Technical
- Relative Strength Index (RSI)
- VEEE 38.85
- APLM 27.85
- Support Level
- VEEE $1.98
- APLM $5.76
- Resistance Level
- VEEE $2.10
- APLM $6.37
- Average True Range (ATR)
- VEEE 0.09
- APLM 0.45
- MACD
- VEEE -0.01
- APLM -0.15
- Stochastic Oscillator
- VEEE 22.17
- APLM 9.38
About VEEE Twin Vee PowerCats Co.
Twin Vee PowerCats Co is a designer, manufacturer, and marketer of recreational and commercial power boats to use for fishing, diving and water skiing, and commercial activities including transportation, eco-tours, fishing, and diving expeditions. The company offers various boat models, including Twin Vee 400 GFX2 CC, Twin Vee 280 GFX2 CC, and Twin Vee 260 Center Console STX, among others. Its products are marketed under two brands, Twin Vee for its catamarans, or dual-hull vessels, and Aquasport for its V-hull boats. The company sells its boats through a network of independent boat dealers across North America, the Caribbean, and Central America who resell the boats to the end user, Twin Vee customers.
About APLM Apollomics Inc.
Apollomics Inc is an clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company programs include vebreltinib (APL-101), a potent, selective c-Met inhibitor for the treatment of non-small cell lung cancer and other tumors with c-Met alterations, and uproleselan (APL-106), a specific E-Selectin antagonist that has the potential to be used adjunctively with standard chemotherapy to treat acute myeloid leukemia.